C4 Therapeutics (CCCC) IPO Opens 40% Higher

Today's IPO for C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC) opened for trading at $26.60 after pricing of its upsized initial public offering of 9.6 million shares of common stock at a public offering price of $19 per share.

Additionally, C4T has granted the underwriters a 30-day option to purchase up to an additional 1.44 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank are acting as joint book-running managers for the offering.

You May Also Be Interested In

• ShengShu Technology explores Hong Kong IPO for over $500 million
• OpenAI unveils ChatGPT for Teens with stronger guardrails to tackle safety risks
• The RoyaLand Company Ltd. Announces Unaudited Fiscal 2026 First Half Financial Results Including Proforma Combined with Recently-Acquired Italian Pro Football Club Savoia FC